Abiopharma

🔍 OYLER JOHN (Director)

Company: BeOne Medicines Ltd. (ONC)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Sold 1,650 shares of American Depositary Shares at $264.8738 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,043.00 | transaction_form_type: 4 | Footnotes: F6, F7, F8
• Sold 1,710 shares of American Depositary Shares at $265.9856 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 333.00 | transaction_form_type: 4 | Footnotes: F6, F7, F9
• Sold 333 shares of American Depositary Shares at $266.6947 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F6, F7, F10
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: H | shares_owned_after: 5,649,640.00
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 481,533.00 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 7,699,158.00 | Footnotes: F2
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 28,204,115.00 | Footnotes: F3
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 9,545,000.00 | Footnotes: F4
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 102,188.00 | Footnotes: F5

Footnotes:

• F1: These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
• F2: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
• F3: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
• F4: These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
• F5: These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
• F6: Each American Depositary Share represents 13 Ordinary Shares.
• F7: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.425 to $265.395, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.45 to $266.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.46 to $266.905, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.